Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum (Q43907774)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2002
edit
Language Label Description Also known as
English
Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum
scientific article published in March 2002

    Statements

    Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum (English)
    Bongkoch Tarnchompoo
    Chawanee Sirichaiwat
    Worrapong Phupong
    Chakapong Intaraudom
    Worachart Sirawaraporn
    Jarunee Vanichtanankul
    Yodhathai Thebtaranonth
    Yongyuth Yuthavong
    1 March 2002
    1244-1252

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit